from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0594/mce2F

LFCtreatmentdescriptionclass of inhibitor

1.141

Amikacinug/mL Amikacintranslation

0.190

Cap5-10ug/mL Capreomycintranslation

0.519

Rox10-50 ug/mL Roxithromycintranslation

0.146

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.115

Rif0.2-5ug/mL Rifampicintranscription

0.897

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.287

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.064

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.118

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.785

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.455

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.484

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.232

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.483

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.941

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.863

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.058

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.172

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.541

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.703

KCN5-20 ug/mL Potassium cyaniderespiration

1.073

NaN30.2-2 mM Sodium aziderespiration

0.251

Nigericin50 uM Nigericinrespiration

0.065

TRC10-150 ug/mL Triclosanrespiration

0.486

TRZ10-25 ug/mL Thioridazinerespiration

1.120

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.302

menadione6-10 ug/mL Menadionerespiration

-0.618

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.267

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.209

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.026

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.419

NRP_1Non-replicating persistence stage 1dosRassociated

-0.411

Amp0.2mg/mL AmpicillincellWall

0.225

Cephalexin20-100 ug/mL CephalexincellWall

-0.299

Cerulenin0.32-5 ug/mL CerulenincellWall

0.030

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.217

EMB10-20 ug/mL EthambutolcellWall

0.301

Eta12-40 ug/mL EthionamidecellWall

-0.103

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.472

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.477

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.166

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.506

BZA0.12 mg/mL BenzamidearomaticAmides

-0.169

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.005

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.220

H2O24 mM hydrogen peroxideDNAdamaging

-0.002

Levo10 ug/mL LevofloxacinDNAdamaging

-0.144

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.343

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.795

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.107

UVUV-irradiationDNAdamaging

0.371

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.344

Antimycin12.5-50 ug/mL Antimycin A?

0.308

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.988

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.346

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.597

PA8240.2-2 ug/mL PA-824?

-0.152

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.004

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.461

Verapamil50 uM Verapamil?

0.099

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.020

methoxatin10-20 ug/mL Methoxatin?